OM · NASDAQ · Medical - Devices

Outset Medical (OM)

Provides the Tablo hemodialysis platform for hospital, clinic, and home care.

$3.17
vs last close−0.12 (−3.72%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue303128272929303129292832
Cost of revenue232320181919192018171618
Gross profit788101011111212121213
534545413433272927302929
Research & development1613131088655565
373332312625222322252324
Selling & marketing252221181515141414131312
General & administrative12101113109898121011
Operating income−45−37−37−31−24−22−16−17−16−18−17−16
−1−1−3−4−4−4−9−2−2−2−2−2
Interest income323222222220
Interest expense336666433333
Other non-operating income−3−2−3−2−2−20−2−2−2−2−1
Income before tax−46−38−40−34−28−26−26−18−17−19−19−18
Income tax expense000000000000
Net income from continuing operations−46−39−40−34−28−26−26−19−18−19−19−18
Net income−46−39−40−34−28−26−26−19−18−19−19−18
EPS, basic−$0.93−$0.77−$11.77−$9.96−$8.30−$7.35−$7.44−$1.04−$1.00−$1.09−$1.03−$0.97
EPS, diluted−$0.93−$0.77−$11.77−$9.96−$8.30−$7.35−$7.44−$1.04−$1.00−$1.09−$1.03−$0.97
Weighted average shares, basic33333331818181819
Weighted average shares, diluted33333331818181819
EBITDA−41−34−32−27−20−18−15−14−14−15−15−13
Depreciation & amortization211121110111
EBIT−43−35−34−28−22−20−16−15−14−16−15−14